These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14583902)

  • 1. Beta-blockers are effective in congestive heart failure patients with atrial fibrillation.
    Meng F; Yoshikawa T; Baba A; Moritani K; Suzuki M; Satoh T; Yokozuka H; Murayama A; Ogawa S
    J Card Fail; 2003 Oct; 9(5):398-403. PubMed ID: 14583902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials.
    Fung JW; Chan SK; Yeung LY; Sanderson JE
    Eur J Heart Fail; 2002 Aug; 4(4):489-94. PubMed ID: 12167389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
    Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
    Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure.
    Kawabata M; Hirao K; Hachiya H; Higuchi K; Tanaka Y; Yagishita A; Inaba O; Isobe M
    J Cardiol; 2011 Sep; 58(2):108-15. PubMed ID: 21831597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide response is heterogeneous during beta-blocker therapy for congestive heart failure.
    Yoshizawa A; Yoshikawa T; Nakamura I; Satoh T; Moritani K; Suzuki M; Baba A; Iwanaga S; Mitamura H; Ogawa S
    J Card Fail; 2004 Aug; 10(4):310-5. PubMed ID: 15309697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure.
    Targoński R; Salczyńska D; Sadowski J; Cichowski L
    Kardiol Pol; 2008 Jul; 66(7):729-36; discussion 737-9. PubMed ID: 18690564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
    Karwath A; Bunting KV; Gill SK; Tica O; Pendleton S; Aziz F; Barsky AD; Chernbumroong S; Duan J; Mobley AR; Cardoso VR; Slater K; Williams JA; Bruce EJ; Wang X; Flather MD; Coats AJS; Gkoutos GV; Kotecha D;
    Lancet; 2021 Oct; 398(10309):1427-1435. PubMed ID: 34474011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Blockers on Discharge From Acute Atrial Fibrillation Are Associated With Decreased Mortality and Lower Cerebrovascular Accidents in Patients With Heart Failure and Reduced Ejection Fraction.
    Abi Khalil C; Zubaid M; Asaad N; Rashed WA; Hamad AK; Singh R; Al Suwaidi J
    Angiology; 2018 Apr; 69(4):316-322. PubMed ID: 28737070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
    Khand AU; Rankin AC; Martin W; Taylor J; Gemmell I; Cleland JG
    J Am Coll Cardiol; 2003 Dec; 42(11):1944-51. PubMed ID: 14662257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation-a meta-analysis.
    Xu T; Huang Y; Zhou H; Bai Y; Huang X; Hu Y; Xu D; Zhang Y; Zhang J
    BMC Cardiovasc Disord; 2019 Jun; 19(1):135. PubMed ID: 31159740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
    Kotecha D; Holmes J; Krum H; Altman DG; Manzano L; Cleland JG; Lip GY; Coats AJ; Andersson B; Kirchhof P; von Lueder TG; Wedel H; Rosano G; Shibata MC; Rigby A; Flather MD;
    Lancet; 2014 Dec; 384(9961):2235-43. PubMed ID: 25193873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
    Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
    Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.